The Ministry of Health has opened an investigation following the death of a young woman in Marrakech after receiving the Johnson & Johnson single-dose vaccine, a ministry statement said.
“The services of the ministry learned on the news of the death of a 33-year-old woman at the Bab Ighli cultural complex in Marrakech, after having received a dose of the vaccine, yesterday, Monday July 26, as well as that of the fainting of a colleague of the deceased woman, “the statement read, stressing that” immediately after that, the ministry began its investigations into the incident and sent a commission to Marrakech to conduct a medical investigation and investigate the circumstances of this incident “.
Khalid Ait Taleb’s department said it “will publish the results of the investigations into this unfortunate incident after the commission’s work is completed.”
A few hours before the release of the supervisory press release, the communications officer for the regional delegation of the Marrakech-Safi Ministry of Health indicated in a statement to MoroccoLatestNews Ar that “the death of the young woman cannot be linked to the vaccine. Johnson & Johnson, noting that many citizens of the city have received the same vaccine without having any serious symptoms or signs.
For his part, Saïd Afif, member of the Scientific Committee in charge of the vaccination campaign, explained that since the start of the national vaccination campaign, no deaths have been recorded in Morocco for the approved vaccines “Sinopharma” and ” AstraZeneca ”, adding that the medical investigation would clarify if there is really a relationship between the death of a young woman in Marrakech and the vaccine“ Johnson & Johnson ”.
Johnson & Johnson vaccine approved in 70 countries
The Ministry of Health, through the National Advisory Committee on Pharmacovigilance, had previously carried out investigations into the suspected blood clots among the beneficiaries of the “AstraZeneca” vaccine which concluded that there had been no deaths. due to the “AstraZeneca” vaccine due to side effects or complications, Afif said in a statement to MoroccoLatestNews Ar.
The member of the vaccination committee added that the scientific committee of the Directorate of Medicines and Pharmacy had previously accepted the approval of the “Johnson & Johnson” vaccine in Morocco, adding that it is approved in around 70 countries.
The pharmacovigilance committee chaired by Professor Rachida Slimani Bencheikh is expected to reveal the circumstances of the death of a young woman in her thirties in Marrakech immediately after receiving the vaccine, while the family of the young woman has stated that the deceased was in good health and did not suffer from any illness.
The deceased young woman is one of about 500 employees in the tourism sector in Marrakech who received the Janssen single-dose vaccine, but she died yesterday afternoon, Monday July 26, moments after receiving the said vaccine.